Jury awards $88 million in first federal Covidien hernia mesh bellwether trial

A federal jury in Boston ordered Medtronic’s Covidien unit to pay $88 million to a Florida couple after finding its hernia mesh failed to warn doctors about serious risks. The verdict is the first federal bellwether in more than 2,400 Covidien mesh cases and the largest compensatory mesh award in U.S. history.

Why it matters: - The $88 million verdict sets a record for compensatory damages in U.S. mesh litigation. - The decision could influence settlement talks across more than 2,400 pending Covidien hernia mesh cases in federal court. - The jury’s finding that doctors were not adequately warned strengthens the failure-to-warn theory driving the litigation.

What happened: - On Aug. 4, 2026, a federal jury in Boston ordered Medtronic to pay Larry Patterson and Tammy Patterson $88 million. - The case was the first federal bellwether trial in the Covidien hernia mesh multidistrict litigation. - U.S. District Judge Patti B. Saris oversaw the trial. - Timothy M. O'Brien of Levin, Papantonio, Proctor, Buchanan, O'Brien, Barr & Mougey led the trial team. - Kelsey Stokes of Stokes & Hobbs tried the case with O'Brien and handled key witnesses.

The details: - Larry Patterson, 61, received a Symbotex hernia mesh during a 2017 hernia repair. - The mesh’s collagen coating dissolved in about seven days, instead of the 30 days doctors were told to expect. - The mesh adhered to Patterson’s bowel, leading to a second surgery. - Surgeons removed the mesh and several inches of his intestine. - The jury awarded $77 million to Larry Patterson and $11 million to Tammy Patterson on her loss-of-consortium claim. - The verdict covers only the Pattersons’ claims. - The case is Patterson v. Covidien Inc., No. 1:22-cv-10153, in the U.S. District Court for the District of Massachusetts. - The MDL, No. 3029, coordinates claims over hernia mesh products including Parietex, ProGrip and Symbotex. - The litigation now includes more than 2,500 cases after the Judicial Panel on Multidistrict Litigation consolidated 900 cases in January 2024. - The parties completed coordinated discovery during 2024 and 2025. - The court scheduled Patterson v. Covidien as the first federal bellwether trial in January 2026. - The trial began in July 2026. - Covidien denied the allegations and argued Patterson’s medical history and other risk factors caused the injuries. - Medtronic said it intends to challenge the verdict through post-trial motions and possibly an appeal. - Levin Papantonio said it can now provide journalists with trial exhibits and documents that were previously sealed.

Between the lines: - The size of the verdict suggests the jury accepted the plaintiffs’ claim that Covidien concealed or understated mesh risks. - A strong bellwether result for plaintiffs can increase pressure on a defendant before later trials in a mass tort case. - The request to review formerly sealed exhibits signals that plaintiffs want the broader litigation record to shape public scrutiny of Covidien’s conduct.

What's next: - Medtronic is expected to pursue post-trial motions. - An appeal remains possible if those motions do not change the outcome. - More bellwether trials could follow as the MDL continues moving toward resolution. - Attorneys for the Pattersons and Levin Papantonio are available for media requests involving the sealed trial materials.

The bottom line: - The first federal Covidien mesh bellwether trial produced a record-setting loss for Medtronic and could reshape the litigation landscape for thousands of pending claims.